Cargando…

Verteporfin suppresses osteosarcoma progression by targeting the Hippo signaling pathway

Verteporfin (VP) is a specific inhibitor of yes-associated protein 1 (YAP1) that suppresses tumor progression by inhibiting YAP1 expression. The present study aimed to determine the inhibitory effect of VP on osteosarcoma and the underlying mechanism of its anticancer effects. Cell viability, cell c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xianliang, Xu, Youjia, Jiang, Chao, Ma, Ziping, Jin, Linguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371961/ https://www.ncbi.nlm.nih.gov/pubmed/34429764 http://dx.doi.org/10.3892/ol.2021.12985

Ejemplares similares

Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway
por: Li, Yang, et al.
Publicado: (2022)

Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway
por: Dong, Liang, et al.
Publicado: (2018)

Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
por: Wang, Dong-Yu, et al.
Publicado: (2016)

miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells
por: Luo, Yongjun, et al.
Publicado: (2019)

Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue Sarcomas
por: Rytlewski, Jeffrey D., et al.
Publicado: (2021)

Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin
por: Brouwer, Niels J., et al.
Publicado: (2021)

The Hippo signaling pathway in gastric cancer: Targeting Hippo for GC treatment
por: Cao, Zhifa, et al.
Publicado: (2023)

Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells
por: Saini, Heena, et al.
Publicado: (2021)

The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression
por: Tu, Chao, et al.
Publicado: (2020)

The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth
por: Morice, Sarah, et al.
Publicado: (2020)

DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer
por: Wang, Dehai, et al.
Publicado: (2022)

SRPX2 Promotes Cell Proliferation and Invasion in Osteosarcoma Through Regulating Hippo Signaling Pathway
por: Wu, Zhiqiang, et al.
Publicado: (2020)

RhoA enhances osteosarcoma resistance to MPPa-PDT via the Hippo/YAP signaling pathway
por: Zhan, Fangbiao, et al.
Publicado: (2021)

Buformin suppresses osteosarcoma via targeting AMPK signaling pathway
por: Ding, Yan, et al.
Publicado: (2020)

DNAJB4 suppresses breast cancer progression and promotes tumor immunity by regulating the Hippo signaling pathway
por: Chen, Yanru, et al.
Publicado: (2023)

New Therapeutic Approach for Targeting Hippo Signalling Pathway
por: Dominguez-Berrocal, Leticia, et al.
Publicado: (2019)

An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression
por: Luu, Anita K., et al.
Publicado: (2018)

Hippo Signaling Pathway in Gliomas
por: Masliantsev, Konstantin, et al.
Publicado: (2021)

OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer
por: Yan, Cheng, et al.
Publicado: (2022)

Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy
por: Hata, Yutaka
Publicado: (2018)

Circular RNA circ_0067741 regulates the Hippo/YAP pathway to suppress lung adenocarcinoma progression by targeting microRNA-183-5p
por: Mo, Jianming, et al.
Publicado: (2022)

Verteporfin Is a Promising Anti-Tumor Agent for Cervical Carcinoma by Targeting Endoplasmic Reticulum Stress Pathway
por: Wang, Meng, et al.
Publicado: (2020)

The Hippo pathway mediates Semaphorin signaling
por: Meng, Zhipeng, et al.
Publicado: (2022)

Artesunate combined with verteporfin inhibits uveal melanoma by regulation of the MALAT1/yes-associated protein signaling pathway
por: Jiu, Xudong, et al.
Publicado: (2021)

Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy
por: Juan, Wen Chun, et al.
Publicado: (2016)

miR-429 inhibits osteosarcoma progression by targeting HOXA9 through suppressing Wnt/β-catenin signaling pathway
por: Sun, Liangzhi, et al.
Publicado: (2020)

Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
por: Ma, Lijuan, et al.
Publicado: (2023)

Photodynamic Therapy with Verteporfin for Corneal Neovascularization
por: Al-Torbak, Abdullah A.
Publicado: (2012)

In vitro effects of verteporfin on ocular cells
por: Ammar, David A., et al.
Publicado: (2013)

Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma
por: Golino, Jihye L., et al.
Publicado: (2023)

The Hippo signaling pathway: from multiple signals to the hallmarks of cancers: Hippo pathway: from multiple signals to the hallmarks of cancers
por: Zhu, Ning, et al.
Publicado: (2023)

Hippo signaling pathway and respiratory diseases
por: Tang, Weifeng, et al.
Publicado: (2022)

Hippo Signaling Pathway in Pancreas Development
por: Wu, Yifan, et al.
Publicado: (2021)

NGF Signaling Interacts With the Hippo/YAP Pathway to Regulate Cervical Cancer Progression
por: Wang, Lijun, et al.
Publicado: (2021)

PCAF Accelerates Vascular Senescence via the Hippo Signaling Pathway
por: Kong, Chaohua, et al.
Publicado: (2022)

Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1
por: Kang, Myoung-Hee, et al.
Publicado: (2017)

DAB2 suppresses gastric cancer migration by regulating the Wnt/β-catenin and Hippo-YAP signaling pathways
por: Wang, Hua, et al.
Publicado: (2020)

The Hippo signaling pathway provides novel anti-cancer drug targets
por: Bae, June Sung, et al.
Publicado: (2016)

The critical role of the Hippo signaling pathway in kidney diseases
por: Sun, Yuting, et al.
Publicado: (2022)

Over-expression of hsa_circ_0088214 suppresses tumor progression by inhibiting Akt signaling pathway in osteosarcoma
por: Hao, Zhiwei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ukn3nbo938nve1f9prmplsjrd2